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Parenteral nutrition (PN) is widely used in the pediatric and 
adult population for patients with short- and long-term intesti-
nal failure. The benefits of this therapy are clear, but there are 
many detrimental effects associated with its use. There is little 
understanding of the underlying mechanisms for many of the 
known complications described with PN. This study represents 
the first report to investigate the intestinal microbiome in those 
patients on PN. Regardless of cause, low intestinal microbial 
diversity correlates with increased incidence of anastomotic 
and infectious complications. An improved understanding of 
the interaction between loss of enteral nutrition, the microbi-
ome, and the host response may lead to therapy to decrease 
complications in an already high-risk population.
Introduction
Parenteral nutrition (PN) is an alternative form of nutrition for 
those patients with short-term gastrointestinal (GI) dysfunc-
tion,1 as well as a life-saving nutrition replacement for patients 
with intestinal failure requiring long-term support.2,3 Although 
essential and clearly beneficial for many, PN use is associated 
with numerous complications ranging from an increase in sys-
temic infections to a loss of immune reactivity.4-8 Previous 
studies have shown distinct physical and immunologic differ-
ences in the intestinal immunology of mice maintained on 
PN.9-15 These changes include increased inflammatory cyto-
kines and decreased regulatory cytokines within the bowel 
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Abstract
Background and Aims: Enteral nutrient deprivation via parenteral nutrition (PN) in a mouse model leads to a local mucosal inflammatory 
response. This proinflammatory response leads to a loss of epithelial barrier function and atrophy of the intestine. Although the underlying 
mechanisms are unknown, a potential contributing factor is the impact PN has on the intestinal microbiome. We recently identified 
a shift in the intestinal microbial community in mice given PN; however, it is unknown whether such changes occur in humans. We 
hypothesized that similar microbial changes occur in humans during periods of enteral nutrient deprivation. Methods: A series of small 
bowel specimens were obtained from pediatric and adult patients undergoing small intestinal resection. Mucosally associated bacteria 
were harvested and analyzed using 454 pyrosequencing techniques. Statistical analysis of microbial diversity and differences in microbial 
characteristics were assessed between enterally fed and enterally deprived portions of the intestine. Occurrence of postoperative infectious 
and anastomotic complications was also examined. Results: Pyrosequencing demonstrated a wide variability in microbial diversity within 
all groups. Principal coordinate analysis demonstrated only a partial stratification of microbial communities between fed and enterally 
deprived groups. Interestingly, a tight correlation was identified in patients who had a low level of enteric microbial diversity and those 
who developed postoperative enteric-derived infections or intestinal anastomotic disruption. Conclusions: Loss of enteral nutrients and 
systemic antibiotic therapy in humans is associated with a significant loss of microbial biodiversity within the small bowel mucosa. These 
changes were associated with a number of enteric-derived intestinal infections and intestinal anastomotic disruptions. (JPEN J Parenter 
Enteral Nutr. 2014;38:392-399)
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wall, leading to a proinflammatory state in the GI tract. There 
is also a decrease in intestinal epithelial cell proliferation and 
an increase in apoptosis with an associated atrophy of the small 
bowel mucosa.16-18 The underlying mechanisms for the above 
changes are unknown, but the immunologic disorder may 
lead to a loss of epithelial barrier function (EBF)18,19 and is 
theorized to increase bacterial translocation through a more 
permeable intestinal mucosa.20-22
Enteral deprivation may help explain the dramatic observa-
tions seen in our PN mouse model. PN provides sufficient 
energy and nutrient needs but puts the intestinal microbiota in 
an abrupt state of nutrient withdrawal. The intestinal micro-
bial population is highly sensitive to local environmental 
alterations and may rapidly change its composition in response 
to such dramatic nutrition deviation from baseline.23,24 In 
mice, administration of PN leads to profound changes in the 
small intestinal microbiota, moving from a Gram-positive 
Firmicutes flora to a Gram-negative Proteobacteria-dominated 
community.25
Although the above-mentioned small bowel and microbial 
changes are well documented in rodent models of PN adminis-
tration, it is less clear whether such changes occur in humans.26-30 
A major limitation of previous studies is that each is based on 
very limited numbers of patients, and only a very superficial 
evaluation of mucosal changes has been investigated. 
Importantly, no previous study has investigated whether the 
administration of PN results in changes in the microbial popula-
tion of the GI tract. Alteration in types of nutrient feeding has 
long been thought to affect the composition of the human intes-
tinal microbiome.31 Such fluctuations have been implicated in 
the development of a number of pathologic conditions, includ-
ing necrotizing enterocolitis, inflammatory bowel disease,32 
obesity,33 and food allergies.34 A deep understanding of the 
microbial shifts associated with each disease process has been 
difficult in humans as each person has a unique microbiome, 
making concrete correlations challenging.35 Whether the com-
plete removal of enteral nutrition (EN) from a portion of the 
intestine affects the composition of the microbial population has 
yet to be tested in humans, yet this extreme modification in 
nutrient delivery has the potential to best address the implica-
tions of nutrients on the alteration of the intestinal microbial 
communities. To address this, we used a series of surgical biopsy 
specimens from the small bowel of patients and compared the 
microbiota with relation to the degree of enteral nutrient depri-
vation. Secondarily, we followed the clinical course of each 
patient from whom a sample was taken.
Methods
Handling of Human Tissue
All experiments were done in accordance with the University of 
Michigan Institutional Review Board (HUM00024263). In all 
cases, the degree to which the small bowel segment was in 
contact with enteral nutrients was recorded. All specimens were 
sent fresh to pathology from the operating room. Adhering to 
sterile technique, a pathologist performed gross examination of 
the specimen. A fresh portion of the specimen was cut and 
placed into sterile RPMI 1640 with glutamine (Invitrogen, 
Carlsbad, CA) and taken to the laboratory for tissue processing 
(see later paragraphs). All samples were de-identified; however, 
the following data were recorded: patient age, diagnosis, sex, 
location of bowel, whether the bowel was exposed to enteral 
nutrients or not, and duration of enteral nutrient deprivation. 
Definition of enteral nutrient deprivation included the follow-
ing: isolated intestinal segments or defunctionalized limbs of 
bowel, without exposure to enteral nutrients. In addition, nutri-
ent deprivation included patients without any enteral nutrients. 
Patients with active inflammatory conditions (eg, Crohn’s dis-
ease, active necrotizing enterocolitis) were excluded.
Bacterial Pyrosequencing
From each segment, tissue was opened, with adherent stool 
rinsed off in sterile media consisting of RPMI 1640 with gluta-
mine (Invitrogen) and 5% fetal bovine serum (FBS; Invitrogen). 
The tissue was then scraped to obtain the mucosally associated 
bacteria and snap-frozen in liquid nitrogen until analyzed. The 
bacterial tag-encoded FLX-Titanium amplicon pyrosequenc-
ing method targeting the V1–V3 variable regions of 16S rRNA 
was used to create amplicon libraries.36 V1–V3 primer sets 
corresponded to 27F (5′-GAGTTTGATCNTGGCTCAG-3′) 
and 519R (5′-GTNTTACNGCGGCKGCTG-3′), along with 
appropriate sample nucleotide barcodes and the Roche (Basel, 
Switzerland) A&B primers. Pyrosequencing was performed 
following established protocols37 at Research and Testing 
Laboratories (Lubbock, TX).
Identified sequences were then classified using the 
Michigan State Ribosomal Database Project (RDP) classifier. 
Analysis of sequenced data was performed using Mothur, an 
open-source, community-supported software for describing 
and comparing microbial communities,38 following the exam-
ple of Costello Stool Analysis with default software settings. 
The metrics we examined were α and β-diversity Unifrac prin-
cipal coordinate analyses.
Another metric to evaluate the microbiota is the inverse 
Simpson index, which is an example of an α-diversity measure 
that describes how much variety exists within a given commu-
nity. The Simpson index always falls between 0 and 1, with 0 
meaning infinite variety and 1 meaning no variety. The inverse 
Simpson index is more intuitive in that higher numbers indi-
cate higher α-diversity (or variety, and thus the greater the 
score, the higher the diversity).
Statistical Analysis
We used α-diversity and Unifrac principal coordinate analysis 
to study the microbial communities. The inverse Simpson 
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index was further used to define the variability in diversity 
depending on degree of enteral nutrient deprivation. An arbi-
trary setting of 10 for the inverse Simpson index was used to 
stratify between low (<10) and high (≥10) diversity.
Results
Demographics
Fifteen samples from 12 different patients were collected for 
analysis of their microbiota between January 2009 and October 
2010 (Table 1). Loop enterostomy takedown resulted in more 
samples than the number of patients. In these cases, 1 limb of 
bowel had exposure to nutrients, and the other was isolated 
from nutrition (ie, in these cases, there was no refeeding of the 
distal limb). There were 6 males and 6 females with a mean ± 
SD age of 9.2 ± 8.4 years (range, 2 days to 22 years). Additional 
items recorded included the disease process and location of the 
bowel. Intestinal samples were ileal (n = 13) or jejunal (n = 2). 
The operative indications for resection were most commonly 
enterostomy takedown (n = 6). Others indications included 
enterocutaneous (EC) fistula takedown (n = 2), small bowel 
obstruction (n = 2, from adhesive disease and anastomotic 
stricture), and 1 case each for ileal atresia and parastomal 
hernia. Underlying pathology included previous cases of nec-
rotizing enterocolitis (n = 3), previous diagnosis of ulcerative 
colitis (n = 3), intestinal atresia, anastomotic stricture, cloacal 
Table 1. Patient Demographics and Clinical Information of Patients From Which Small Bowel Was Collected and Studied.




Modulator Prior Infections Complication
Newborn1*
F/2 d
Ileal atresia NPO  
Newborn2*
F/2 d








α Strep, line 
infection




Previous NEC MF not fed Gentamicin (P) Klebsiella UTI  
MF2†
M/17 y
Previous blunt trauma MF not fed  
Partial1‡
M/3 mo
Previous NEC PN and feeds Gentamicin (P) Klebsiella UTI  
Partial2
M/2 mo

















History of malrotation, 
jejunal stricture
Full feeds, clear 






Previous blunt trauma Full feeds  
Full feeds3
M/17 y










IBD with small bowel 
obstruction
Full Feeds Pip/Tazo and 
metronidazole (P)





EC fistula following 
jejunal tube
Full feeds  
Full feeds7
F/7 y
Previous NEC Full feeds Pip/Tazo (P) Enterococcus, 
Pseudomonas
Anastomotic leak
* †‡ denote samples from the same patient. A, active (denotes current therapy); Amox, amoxicillin; EC, enterocutaneous; H, historic (refers to prior 
treatment that ended 2 weeks or more before operation); IBD, inflammatory bowel disease; ID, identifier; MF, mucus fistula; MSSA, methicillin- 
sensitive Staphylococcus aureus; NEC, necrotizing enterocolitis; NPO, nil per os; P, previous (refers to therapy continuing up to within 1 week of  
operation); Pip/Tazo, piperacillin and tazobactam; PN, parenteral nutrition; UTI, urinary tract infection.
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Figure 1. Phylum level analysis after Ribosomal Database Project (RDP) classification of pyrosequenced small bowel mucosa-
associated bacteria samples. Groups of patients are broken down by degree of enteral nutrition, as well as by separating the 2 neonatal 
samples. Mucous fistula denotes bowel completely unexposed to nutrients, and partial feeding meant intestine where <20% of nutrients 
entered the gastrointestinal tract. NPO, nil per os.
exstrophy, total colonic Hirschsprung disease, EC fistula, and 
trauma.
Seven samples were from fully fed segments of bowel and 
3 were partially fed. The partially fed patients received the 
majority of nutrients parenterally (>80%), as only trophic feed-
ings were tolerated in these patients. All samples in the par-
tially fed group were chronically (over 2 weeks) on PN support. 
Five samples were unfed, 3 of which had no EN for at least 6 
weeks (65, 47, and 42 days). Two of these came from patients 
with mucus fistulae out of continuity of enteric flow but receiv-
ing either full enteral feeds or partial feeds. The other patient 
was PN dependent with no EN for more than 2 months. Two 
samples were from neonates who never received enteral 
feedings.
454 Pyrosequencing, Biodiversity, and 
Correlation to Clinical Outcomes
Figure 1 shows the intestinal mirobiota sorted by phylum. 
Quite similar to most human data, there was marked heteroge-
neity among the samples.39 Three of these samples, however, 
stood out above all others. These were the 2 segments from the 
same 2-day-old infant and the sample from a patient who was 
without enteral nutrients for more than 2 months. These sam-
ples were distinct in that there was a marked loss of diversity in 
these patients who had little to no nutrient exposure. As it is 
known that neonatal fecal microbes are quite different from 
those in adults,40,41 the latter patient’s microbiome (nil per os 
[NPO] for >2 months), which was composed virtually of all 
Proteobacteria, is more relevant to this study. The data suggest 
that prolonged periods of enteral deprivation can lead to a 
marked change in intestinal mucosal microbiota with a decline 
in its diversity.
A further breakdown of the bacterial genus is shown in 
Table 2. In the table, 3 representative nonfed and fed micro-
bial populations are shown. Characteristic of human micro-
bial populations, each patient had a unique distribution, but 
some important distinctions are found. Although there is a 
large overlap in speciation and no statistically significant 
differences found, some groups were expanded in the fed 
group (Staphylococcus, Pseudomonas, Campylobacter, 
Propionibacterium, Chryseomonas) and others in the enter-
ally deprived group (Enterobacter, Shigella, Klebsiella, and 
Fusobacterium).
To better characterize and quantify differences in the intes-
tinal flora between individuals, Unifrac principal coordinate 
analysis (PCoA) was applied to the samples. In PCoA, differ-
ences between microbial communities are first divided into 
multiple weighted components based on their genetic 
sequences or operational taxonomic units. Figure 2 shows the 
components that accounted for the largest percentage of the 
differences between communities and is expressed as an x-y 
plot. This unweighted PCoA plot of the first 2 axes accounted 
for 20.5% of the total differences between microbial commu-
nities in fed vs unfed bowel. In an unweighted analysis, only 
the presence or absence of a bacterium is counted. Because of 
this, the neonatal samples were distinctly different from the 
other samples. A clear separation of groups based on feeding 
status is not seen. There is a trend of unfed or partially fed 
samples clustering toward the bottom right and fully fed 
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samples clustering to the top left. This indicates an underlying 
similarity among the unfed vs fed intestinal samples. But, as 
with Table 2, there is no clear distinction of these groups based 
solely on feeding status.
To further analyze the microbiome data, we next performed 
an analysis of biodiversity. Figure 3 shows an analysis of the 
samples using inverse Simpson indices. At initial analyses, 
there appeared to be little correlation between α-diversity and 
feeding status of the patients. However, a further analysis was 
performed examining those patients who had a postoperative 
infectious complication. Seven such postoperative complica-
tions were found, which included 3 anastomotic problems (2 
with complete disruption), 2 abdominal wound infections 
(Klebsiella pneumoniae, Candida albicans in 1 patient and 
methicillin-sensitive Staphylococcus aureus [MSSA] in the 
other), 1 central venous line infection (K pneumoniae), and 1 
case of recurrent enterocolitis.
Interestingly, the proportion of samples with a lower 
α-diversity (or a lower inverse Simpson index, <10) was sig-
nificantly (P < .01 using χ2 analysis) greater (all but one 
patient) in the group of patients who had the above-listed post-
operative complications, whereas those having a higher inverse 
Simpson index fell into the group that was far less prone to 
infectious complications. In fact, no patient had infectious 
complications with an inverse Simpson index >10. This sug-
gested that those patients with lower levels of biodiversity had 
an increased susceptibility to infections or potentially had a 
more virulent type of bacteria that predisposed them to these 
complications.
Discussion
Although the causality is not fully established, it was inter-
esting that a significant increase in infectious and anasto-
motic complications was associated in those patients who 
had loss of microbial diversity. Such an increase in infec-
tious complications has been well established in patients 
receiving PN,5,20,42 and the results suggest that lower diver-
sity in the intestinal microbiome may affect these infectious 
complications. The lower diversity was not clearly defined 
in the fed and enterally deprived groups as hypothesized but 
rather seems multifactorial. Importantly, the 1 sample from 
which enteral nutrients was withheld for more than 2 months 
did have the lowest diversity. An in-depth investigation of 
Table 2. Representative 454 Pyrosequencing Results at the Genus Level From 3 Nonfed (Excluding Neonatal Specimens) and 3 
Enterally Fed Portions of Bowel.
Bacterial Genus NPO NPO NPO Enteral Enteral Enteral
Staphylococcus 22 1274 523 962 1646 1597
Enterococcus 33 1835 210 1385 57 199
Klebsiella 11876 0 231 218 43 571
Pseudomonas 1 466 538 1085 1351 1955
Shigella 1475 43 186 210 82 197
Bifidobacterium 0 0 37 0 54 12
Corynebacterium 7 806 247 532 621 434
Campylobacter 9 1 131 681 35 289
Fusobacterium 1 1 1508 0 3 47
Enterobacter 656 284 227 326 105 202
Anaerococcus 6 263 88 259 152 211
Citrobacter 456 1 282 56 21 447
Streptococcus 2 199 334 167 285 215
Propionibacterium 1 58 19 291 284 166
Proteus 2 240 42 133 87 168
Finegoldia 10 527 61 171 149 149
Clostridium 68 0 45 69 2 96
Delftia 0 0 198 1304 1 8
Prevotella 0 384 322 248 55 25
Chryseomonas 4 9 40 142 176 98
Allobaculum 0 0 172 975 3 0
Veillonella 13 113 68 0 38 18
Minor genera (<1000) 110 1178 2335 2455 1115 2226
Total called 14,752 7682 7844 11,669 6365 9330
Total sequences 16,921 8542 9137 13,773 7344 12,237
Note the broader representation of bacteria from multiple bacterial genera. As well, note certain predominant Gram-negative groups in the nonfed pa-
tients, including Enterobacter, Shigella, Klebsiella, and Fusobacterium. NPO, nil per os.
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Figure 2. Unweighted Unifrac principal coordinate analysis of control and parenteral nutrition small bowel samples. Axis-1 (x) and 
axis-2 (y) account for 11.9% and 8.6% of overall differences, respectively.
Figure 3. Inverse Simpson index and enteral nutrition. All 
patients outside of the newborn period with a sample that 
scored less than 10, signifying a less diverse microbiota, were 
complicated with an infectious or anastomotic complication (*). 
NPO, nil per os.
more completely NPO individuals is needed to further sub-
stantiate this finding. It is also important to note that other 
confounding factors that could influence microbial diversity 
would include repetitive use of antimicrobial agents, as 
given in many of our patients in this study.
In both humans and rodents, the dominant intestinal phyla 
of bacteria are Firmicutes and Bacteroides, composed of 
mostly Gram-positive bacteria.43 Although the general trend of 
more Firmicutes and Bacteroides is present, the specific sub-
phylum composition of the microbiota is quite variable. Thus, 
it was not surprising to see this overall diversity between the 
patients we examined. Our laboratory’s mouse model of enteral 
nutrient deprivation with PN administration demonstrates a 
marked shift of the intestinal microbiota from that of a 
Firmicutes-dominant flora to that of a Proteobacteria-dominant 
population. Although there was a definite trend toward this 
shift in the human samples, a significant loss of diversity was 
not shown in all unfed portions of small intestine. However, 
this trend is best seen in the individual who was enterally 
deprived for 2 months and had a nearly complete shift to a 
Proteobacteria profile.
When specifically looking at the unfed samples, one could 
argue based on the RDP data (Figure 1) that 2 of the 5 unfed 
specimens are not dissimilar to the partially fed and fed sam-
ples. However, when considering the unfed specimens, it is 
critical to consider the patient history. The neonates, never hav-
ing received food, had low diversity as expected.44 The third of 
the 5 patients who was totally NPO for 65 days showed a dra-
matic loss in microbial diversity. The other 2 samples were 
from mucus fistulae from patients with loop enterostomies. 
One may expect these samples to look more like the patient 
NPO for 65 days as these patients were out of intestinal conti-
nuity for a similar duration. Both of the patients with mucus 
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fistulae were fed in their proximal limb. This is an important 
consideration as the bacterial contents from the proximal (fed 
limb) may have colonized the distal limb, resulting in greater 
diversity in this group. This could be the case as the stoma 
drains from the same stomal skin site into the same stool col-
lection apparatus.
It was striking to note that the patients who developed 
infectious and anastomotic complications had a significantly 
lower microbial diversity using the inverse Simpson index 
regardless of feeding status. Other factors may influence the 
heterogeneity of microbes. One example could be patient-
specific antimicrobial use that could disrupt the intestinal 
microflora.45 In this study, 4 of the 6 fed or partially fed 
patients who experienced a complication were on an antibiotic 
regimen at the time of the operation or recently completed 
antibiotic treatment prior to surgery (Table 1). There may be 
other contributing factors leading to loss of microbial diver-
sity that were not uncovered in the current study, including 
exposures to other patients or pharmacologics that could 
influence the GI tract. Nevertheless, these data suggest a 
strong correlation between loss of microbial diversity and an 
aberration of underlying physiology of the bowel wall, lead-
ing to higher rates of infectious complications.
One of the limitations of this study is the relatively low 
sample numbers and a highly heterogeneous patient popula-
tion. We also acknowledge that the cutoff of 10 for the 
inverse Simpson index is somewhat arbitrary, and further 
validation of this value is required to increase the robustness 
of this study. Furthermore, we have used pyrosequencing 
data to define the microbiota. Although a widely accepted 
method for analysis of the microbiome, currently there is 
little application of this technique in a clinical setting. These 
data provide a much more diverse set of microbes alluding 
to the presence of unculturable intestinal bacteria, yet clini-
cally we must rely on culture data. Our analysis of the 454 
data was also limited. Potentially, a much more complex 
examination could have been done. However, we believe 
that the data presented demonstrate the changes in microbial 
diversity and fit the needs of this study. Despite these limi-
tations, we believe that our study provides valuable insight 
into the complex interaction between the host and its intes-
tinal microbiota.
In conclusion, this study showed that a loss in microbial 
diversity is associated with an increase in postoperative 
microbial infections and other major GI surgical complica-
tions. It is possible that enteral nutrient deprivation, among 
other factors, leads to a shift in the microbiome and thus a 
loss of microbial diversity. This may be due to an aberra-
tion in host response to microbial infection. This is evident 
by the increase in infectious and anastomotic complications 
in those with decreased diversity. With further investiga-
tion, this knowledge could lead to therapies aimed at 
improving the interaction between the microbiota and the 
host inflammatory signaling cascade to decrease periopera-
tive complications.
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